---
sidebar_position: 33
---
           <p class="stitle-article-norm">Functionality of Eudamed</p>
   <p class="norm">1.&nbsp;&nbsp;The Commission shall, in collaboration 
with the MDCG, draw up the functional specifications for Eudamed. The 
Commission shall draw up a plan for the implementation of those 
specifications by 26 May 2018. That plan shall seek to ensure that 
Eudamed is fully functional at a date that allows the Commission to 
publish the notice referred to in paragraph&nbsp;3 of this 
Article&nbsp;by 25 March 2020 and that all other relevant deadlines laid
 down in <a href='../CHAPTER X/Article 123 - Entry into force and date of application'> Article 123</a> of this Regulation and in <a href='../CHAPTER IX/Article 113 - Penalties'> Article 113</a> of 
Regulation&nbsp;(EU)&nbsp;2017/746 are met.</p>
   <p class="norm">2.&nbsp;&nbsp;The Commission shall, on the basis of 
an independent audit report, inform the MDCG when it has verified that 
Eudamed has achieved full functionality and Eudamed meets the functional
 specifications drawn up pursuant to paragraph&nbsp;1.</p>
   <p class="norm">3.&nbsp;&nbsp;The Commission shall, after 
consultation with the MDCG and when it is satisfied that the conditions 
referred to in paragraph&nbsp;2 have been fulfilled, publish a notice to
 that effect in the <span class="italics">Official Journal of the European Union</span>.</p>
   <p>
      
      
   </p>
   